IQVIA Archives -

Today’s rare disease landscape comprises of around 7,000 different diseases. With a broad and diverse range of symptoms

Medical Informatics and Rare Disease: a bridge between two worlds

https://pharmaphorum.com/views-and-analysis/medical-informatics-and-rare-disease-a-bridge-between-two-worlds/

Market Access/ Views & Analysis/ Views and analysis

Pharma’s post-pandemic launch performance problem: what’s the prognosis?

mike.hammerton@pharmaphorum.com COVID-19, IQVIA, launch excellence, pandemic, Sarah Rickwood 0 Comment

The prescription medicine market has recovered from the wild swings of the early pandemic with renewed growth. COVID

Pharma’s post-pandemic launch performance problem: what’s the prognosis?

https://pharmaphorum.com/market-access-2/pharmas-post-pandemic-launch-performance-problem/

Deep Dive/ Market Access/ Views & Analysis

ICSs: improving patient and market access at a local level

mike.hammerton@pharmaphorum.com Deep Dive, Deep Dive: Market Access, Dr Paul Tunnah, IQVIA, Jim McArdle, market access, Matthias Winker, Steven Ferguson, Uday Bose 0 Comment

Integrated Care Systems (ICSs) – 42 partnerships of health and care organisations who will plan and deliver more

ICSs: improving patient and market access at a local level

https://pharmaphorum.com/market-access-2/icss-improving-patient-and-market-access-at-a-local-level/

Oncology/ Views & Analysis/ Views and analysis

ASCO ’22 preview: Putting patients first

Jonah Comstock asco, ASCO 2022, ASCO preview, IQVIA 0 Comment

For the first time since 2019, the American Society of Clinical Oncology (ASCO) annual meeting will be an

ASCO ’22 preview: Putting patients first

https://pharmaphorum.com/views-analysis-oncology/asco-22-preview-putting-patients-first/

News/ News/ Sales and Marketing

US meds spending spiked last year, but will fall quickly

Phil Taylor COVID-19, IQVIA, medicines spending, US 0 Comment

Prescription drug use in the US soared last year, as might be expected during a pandemic, but is

US meds spending spiked last year, but will fall quickly

https://pharmaphorum.com/news/us-meds-spending-spiked-last-year-but-will-fall-quickly/

Debates/ Market Access/ Views & Analysis/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand

Medical Informatics and Rare Disease: a bridge between two worlds

mike.hammerton@pharmaphorum.com IQVIA, medical informatics, rare disease, rare disease research 0 Comment

With more than 6,000 different diseases comprising the rare disease (RD) landscape, connecting patients and practitioners with the

Medical Informatics and Rare Disease: a bridge between two worlds

https://pharmaphorum.com/webinars/medical-informatics-bridge-between-two-worlds-iqvia/

Debates/ Market Access/ Views & Analysis/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand

ICSs – an opportunity to improve Patient & Market Access at a local level

mike.hammerton@pharmaphorum.com integrated care systems, IQVIA, market access, NHS, NHS legislation, UK market access 0 Comment

With the new Health and Care Bill edging ever closer to receiving Royal Assent, life sciences companies in

ICSs – an opportunity to improve Patient & Market Access at a local level

https://pharmaphorum.com/webinars/integrated-care-systems-opportunity-to-improve-patient-market-access/

Deep Dive/ R&D/ Views & Analysis

Medical Informatics in Rare Disease – the bridge between two worlds

mike.hammerton@pharmaphorum.com Deep Dive, Deep Dive: Research and Development, IQVIA, Joanne M Hackett, rare disease, research and development 0 Comment

Rare diseases bring with them a multitude of challenges for those affected, their relatives and care providers. Modern

Medical Informatics in Rare Disease – the bridge between two worlds

https://pharmaphorum.com/r-d/medical-informatics-in-rare-disease/

News/ News/ Patients

Rare diseases have tenfold higher impact on healthcare costs; study

Phil Taylor Chiesi, IQVIA, Rare Disease Day, Rare diseases 0 Comment

A new study has suggested that the economic burden posed by rare diseases is around 10 times higher

Rare diseases have tenfold higher impact on healthcare costs; study

https://pharmaphorum.com/news/rare-diseases-have-tenfold-higher-impact-on-healthcare-costs-study/

Trending

IQVIA

Login